| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 09/14/2004 | US6790944 Immunoglobulin a; for diagnosis and therapy; polymerase chain reaction (pcr); northern blot analysis; drugs |
| 09/14/2004 | US6790826 Human haemopoietic maturation factor |
| 09/14/2004 | US6790658 Nucleotide sequences coding polypeptide for use in the treatment and prevention of wounds, angiogenesis, restenosis, atherosclerosis, inflammation, nervous system disorders and cancer |
| 09/14/2004 | US6790649 Phex gene (phosphate regulating gene with homologies to endopeptidases on x chromosome); for treatment of x-linked hypophosphatemia (xlh), a phosphate homeostasis disorder; retardation, bone, renal and metabolism disorders |
| 09/14/2004 | US6790647 Genetically engineered, feed back desensitized lyase for biosynthesis of arginine from glutamate in escherichia |
| 09/14/2004 | US6790645 Oxidation of a cyclohexanone derivative using a brevibacterium cyclohexanone monooxygenase |
| 09/14/2004 | US6790644 1,3-dicarbonyl-dioxygenase—a new c-c-bond cleaving enzyme |
| 09/14/2004 | US6790640 Method of increasing conversion of a fatty acid to its corresponding dicarboxylic acid |
| 09/14/2004 | US6790639 Bone morphogenic proteins; for regulating bone homeostasis, adiposity, and calcification of atherosclerotic plaques |
| 09/14/2004 | US6790630 Glycoproteins; pepsin inhibitors; for detection of heartworm infection in dogs, cats |
| 09/14/2004 | US6790629 Receptor polypeptide for use in the treatment and diagnosis of painful syndromes |
| 09/14/2004 | US6790628 Screening granulocyte colony stimulating factor(g-csf) poly-peptide analogs to use as g-csf replacements or antagonists; sensitizing cells to chemo/radiotherapy; treating hemato-poietic, neurological or reproduction related conditions |
| 09/14/2004 | US6790622 Tumor suppressor encoding nucleic acid, PTX1, and methods of use thereof |
| 09/14/2004 | US6790619 Plant phosphomevalonate kinases |
| 09/14/2004 | US6790434 Sunscreen agents; mixture of deactivated bacteria and plant extract |
| 09/14/2004 | CA2113829C Novel type of gram positive replicon and construction of recombinant vectors containing same |
| 09/14/2004 | CA2071924C Hepatocellular carcinoma oncogene |
| 09/10/2004 | WO2004076660A1 Virus-adsorbing protein and use thereof |
| 09/10/2004 | WO2004076659A2 Method for the production of evolved microorganisms which permit the generation or modification of metabolic pathways |
| 09/10/2004 | WO2004076648A2 Clinically relevant animal model of human breast cancer and vegf involement in desmoplastic response. |
| 09/10/2004 | WO2004076644A2 A composition for delivering an agent to a target cell and uses thereof |
| 09/10/2004 | WO2004076643A2 CIRCULATING TUMOR CELLS (CTC’s): EARLY ASSESSMENT OF TIME TO PROGRESSION SURVIVAL AND RESPONSE TO THERAPY IN METASTATIC CANCER PATIENTS |
| 09/10/2004 | WO2004076638A2 Polynucleotides and polypeptides in plants |
| 09/10/2004 | WO2004076637A2 Cell-polymer fiber compositions and use thereof |
| 09/10/2004 | WO2004076636A2 A novel human g-protein coupled receptor, hgprbmy23, expressed highly in kidney |
| 09/10/2004 | WO2004076632A2 Methods of screening for trpm5 modulators |
| 09/10/2004 | WO2004076629A2 METHODS AND CONSTRUCTS FOR EVALUATION OF RNAi TARGETS AND EFFECTOR MOLECULES |
| 09/10/2004 | WO2004076621A2 Compositions of nucleic acids for treating and detecting influenza virus |
| 09/10/2004 | WO2004076615A2 Immunomodulating probiotic compounds |
| 09/10/2004 | WO2004076492A2 Rubber treatment method |
| 09/10/2004 | WO2004076054A2 Dry chemistry, lateral flow-reconstituted chromatographic enzyme-driven assays |
| 09/10/2004 | WO2004075988A2 Methods of immunomodulation in animals |
| 09/10/2004 | WO2004062583A3 Vaccine and method for preventing biofilm formation |
| 09/10/2004 | WO2004044204A3 Variable fragments of single-chain camelide antibodies and uses thereof for diagnosing and treating various pathologies |
| 09/10/2004 | WO2004035070A9 Induction of gene expression using a high concentration sugar mixture |
| 09/10/2004 | WO2004025253A3 Method of visualizing proteins bound to protein-binding membranes |
| 09/10/2004 | WO2004013604A3 Novel procedure for growth, imaging, and enumeration of microbial colonies for serological or screening assays |
| 09/10/2004 | WO2004009795A3 Dna and amino acid sequences of a tyrosine ammonia lyase enzyme from the bacterium rhodobacter sphaeroides |
| 09/10/2004 | WO2004009759A3 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 09/10/2004 | WO2003099232A3 Dna and amino acid sequences of a tyrosine-inducible tyrosine ammonia lyase enzyme from the yeast trichosporon cutaneum |
| 09/10/2004 | WO2003087123A3 Methods and kits for testing mutagenicity |
| 09/10/2004 | WO2003076643A3 Method of making cs6 antigen vaccine for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections |
| 09/10/2004 | WO2003045230A3 Novel compositions and methods for cancer |
| 09/10/2004 | WO2003038061A3 Ehrlichia disulfide bond formation proteins and uses thereof |
| 09/10/2004 | WO2003003979A3 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 09/10/2004 | WO2002094780A3 Kinases and phosphatases |
| 09/10/2004 | CA2517235A1 Methods and constructs for evaluation of rnai targets and effector molecules |
| 09/10/2004 | CA2517082A1 Clinically relevant animal model of human breast cancer and vegf involvement in desmoplastic response |
| 09/10/2004 | CA2517074A1 Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection |
| 09/10/2004 | CA2516795A1 Circulating tumor cells (ctc's): early assessment of time to progression,_survival and response to therapy in metastatic cancer patients |
| 09/10/2004 | CA2516651A1 Methods of screening for trpm5 modulators |
| 09/10/2004 | CA2516645A1 Abiotic stress responsive plant transcription factor polynucleotides and polypeptides and use thereof for generating transgenic plants |
| 09/10/2004 | CA2516546A1 Dry chemistry, lateral flow-reconstituted chromatographic enzyme-driven assays |
| 09/09/2004 | US20040176582 Expression vector comprising osteocalcin promoter and nucleotide sequence coding bone morphogenic protein for treatment and prevention of osteoporosis |
| 09/09/2004 | US20040176571 Genetically modified cholera toxin (CT-CRM) comprising reduced toxicity and enhanced immunological response for use in preparation of vaccines against parasitic infection |
| 09/09/2004 | US20040176570 Intermediates and enzymes of the non-mevalonate isoprenoid pathway |
| 09/09/2004 | US20040176568 Nucleic acids encoding modified parathyroid hormone |
| 09/09/2004 | US20040176285 Tip39 polypeptides |
| 09/09/2004 | US20040175831 Strains "fil", stress-resistant under fermentation and/or growth conditions |
| 09/09/2004 | US20040175816 Method for cloning and expression of OkrAI restriction endonuclease and methyltransferase |
| 09/09/2004 | US20040175810 by hydrating acrylonitrile in an aqueous solution; reactor has a pumping circuit in which a part of the reaction mixture is circulated by a pump and in which at least one heat exchanger is arranged |
| 09/09/2004 | US20040175807 Beta1, 3-galactose transferase and dna encoding the enzyme |
| 09/09/2004 | US20040175805 Method for fermentative preparation of S-adenosylmethionine |
| 09/09/2004 | US20040175803 Interferon-alpha induced gene |
| 09/09/2004 | US20040175798 Expression system for recombinant proteins |
| 09/09/2004 | US20040175791 DcR3 polypeptide, a TNFR homolog |
| 09/09/2004 | US20040175789 for drug screening asthma, chronic obstructive pulmonary disease, emphysema, chronic bronchitis, acute respiratory distress syndrome, cough and acute bronchitis drugs; genetic engineering |
| 09/09/2004 | US20040175787 for treating spastcity, trigeminal neuralgia, asthma, cough, emesis, ulcers, urinary incontinence and cocaine addiction |
| 09/09/2004 | US20040175782 Using chlamydomonas to modifiy heterocyclic compounds to chemically distinct final products which are useful in pharmaceutical, agrichemical, nutraceutical, ecological, hazardous waste and food processing |
| 09/09/2004 | US20040175778 Method for increasing productivity of secondary metabolite by conferring drug-resistant mutations |
| 09/09/2004 | US20040175731 Preparing transgenic microorganism comprising modified intercellular adhesion (ica) locus and which generates cell surface proteins with altered poly-N-acetyl glucosamine (PNAG) side chain profile for use in vaccine development; bactericides |
| 09/09/2004 | US20040175730 Comprises nucleotide sequences coding polypeptide associated with vascular permeability or proliferation of endothelial cells for treating intestinal malabsorption syndrome |
| 09/09/2004 | US20040175719 Nucleotide sequences probes comprised of 20-60 bases for use as diagnostic tools and controls in genic analysis; bioassay |
| 09/09/2004 | US20040175714 Human protooncogene kg-20 and protein encoded therein |
| 09/09/2004 | US20040175711 using genetically engineered vector and trichoderma host; can be obtained independently of the saponin content of a soybean extract |
| 09/09/2004 | US20040175704 Compositions and methods for polynucleotide sequence detection |
| 09/09/2004 | US20040175697 Methods of isolating rna-binding proteins and compositions related to the same |
| 09/09/2004 | US20040175412 Capsules containing vital cells or tissues |
| 09/09/2004 | US20040175393 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and imunological therapies based thereon |
| 09/09/2004 | US20040175391 Diluting manure in aqueous medium to slurry; separating unwanted fecal matter; solid/liquid phase centrifuging; diluting high density liquid fraction to specific gravity wherein the oocysts are no longer buoyant; free of potassium dichromate |
| 09/09/2004 | US20040175372 Inhibits rotavirus infection and other pathogenic microorganisms; viricides; preventing and treating diarrhea of mammals, livestock, and poultry |
| 09/08/2004 | EP1455186A1 Screening method |
| 09/08/2004 | EP1454991A1 Coryneform bacterium transformed to utilize methanol as carbon source |
| 09/08/2004 | EP1454990A1 Process for producing unsaturated fatty acid-containing oils |
| 09/08/2004 | EP1454980A2 Female sex hormone degrading bacteria and use thereof |
| 09/08/2004 | EP1454917A2 Diabody-type bispecific antibody |
| 09/08/2004 | EP1454534A1 Microcapsules and oral compositions containing the same |
| 09/08/2004 | EP1453982A2 Modulating urea degradation in wine yeast |
| 09/08/2004 | EP1453968A2 Bgl4 beta-glucosidase and nucleic acids encoding the same |
| 09/08/2004 | EP1453967A2 Bgl5 beta-glucosidase and nucleic acids encoding the same |
| 09/08/2004 | EP1453964A2 Genes coding for stress resistance and tolerance proteins |
| 09/08/2004 | EP1453963A2 A structure for presenting desired peptide sequences |
| 09/08/2004 | EP1453952A2 Compositions and methods for normalizing assays |
| 09/08/2004 | EP1453856A1 Beta-amyloid binding factors and inhibitors thereof |
| 09/08/2004 | EP1453850A2 Egviii endoglucanase and nucleic acids encoding the same |
| 09/08/2004 | EP1453547A2 Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor |
| 09/08/2004 | EP1453543A2 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 09/08/2004 | EP1453534A1 A process for the preparation of a non-toxic anthrax vaccine |
| 09/08/2004 | EP1453383A2 A novel saitohin gene and uses of same |
| 09/08/2004 | EP1294867B1 Human site-1 protease promoter |